Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
Sambhal DM Dr. Rajendra Pensia went to meet Sant Premanand Maharaj at his Shriradha Keli Kunj in
After the controversy over the use of animal fat in Tirupati's famous Laddu Prasadam, now the tem
Bollywood actor Varun Dhawan is busy preparing for the release of his upcoming film Baby John. Th
The parliamentary committee considering the Waqf Amendment Bill is going to support the governmen
Famous comedian Samay Raina is now trying to make his life normal again after the controversy ove
All flights to the Middle East canceled: Many airlines decided Israel-Lebanon tension; See list
Keeping in mind the safety of passengers amid the ongoing tension in the Middle East, many major
In our country, walking has been a very old tradition, which is considered a spiritual way to con
Delhi Chief Minister Arvind Kejriwal's PA Vibhav Kumar, who is embroiled in the Aam Aadmi Party's
Sonakshi Sinha, daughter of Bollywood veteran actor Shatrughan Sinha, has now become Mrs from Mis
Chief Minister Yogi has taken a big step for the Kanwar pilgrims. Chief Minister Yogi said that t
